Resources

In this issue: PPTA Members Gather in Chicago for the 2024 Business Forum; Plasma Awareness Efforts Continue in China; Hypotensive Adverse Events Among U.S. Source Plasma Donors -- PlasmaVigilance II; International Plasma Awareness Week Celebrates Plasma Donors Around the World; Highlights from the 2024 Plasma Protein Forum; Looking Ahead: Post-Election in the U.S.; PPTA Partners with Patient Groups to Showcase the Unique Value of Plasma on Capitol Hill; Plasma Donor Spotlight: Nora Kaddar.

As a follow up to the 2021 PPTA study, “Plasmavigilance – Adverse Events Among U.S. Source Plasma [SP] Donors,” published in Transfusion, PPTA analyzed hypotensive adverse events (HAE) rates and SP donor characteristics that may be predictors of a HAE.